SBIR/STTR Research Award
Inducing Dental Implant Bone Formation to Treat Peri implantitis
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INTEGRATED, LLC
- Proposal award date
- 2017-09-15
- Contract end date
- 2019-08-31
- UEI
- JZG9BKYXTVD5
- Solicitation number
- PA16-302
- Topic code
- 100
Research abstract
Project Summary Abstract
The interdisciplinary research team at Integrated LLC has addressed a significant clinical need by developing
a nanotech bioactive water based surface coating for titanium and titanium alloy based implants based on
their advances in nanotechnology stem cell biology Our recently published data show that several of our
peptides bind selectively and with high affinity to titanium and titanium alloys that are now used for dental
implants and for correction of axial and craniofacial skeletal bone defects and joint replacements Using this
implant surface binding peptide as an anchor in combination with another small protein molecule enables us to
introduce a bioactive function Here we chose as a proof of concept a small molecule we discovered that
transiently activates the Wnt pathway for osteogenesis Other bioactive functions such as an anti microbial to
control biofilms is also envisioned This technology is water based and the bifunctional small molecule
approach serves to control the presentation of the biologically active peptides or protein at the implant
interface to ensure cellular bioactivity This promising nanotech bioactive coating technology is designed to
improve outcomes for all patients including those challenged with advanced age or systemic diseases that are
not now candidates for implants because of their high risk status The coating also builds on the success of
titanium surfaces to activate Wnt signals Building upon the team`s accumulated expertise in bio
nanotechnology materials science stem cell biology osteogenesis and craniofacial biology we developed
peptides that mimic the characteristics of a biological surface on titanium or titanium alloy implantable material
surfaces thereby producing a biomimetic hard soft interface that promotes cell attachment while
simultaneously directing the differentiation of the attached cells to osteogenic lineages in a single step Our
premise is that through the design of a self organized bioactive interface on the implant surface we can further
activate the canonical Wnt signaling pathway to direct the differentiation of stem cells to osteogenic lineages
and improve osteointegration Additionally the coating can be used to re treat previously placed implants that
are failing due to bone loss from peri implantitis to extend their useful life Aim Characterize the stability and
temporal capacity of our biomimetic interface to retain Wnt signaling in vivo using a rabbit model well known to
the implant industry
Project Narrative
Dental implants are successful but we desire to expand their therapeutic benefit to patient cohorts now
considered too risky Using the I Corps customer discovery process we found dentists wanted predictable
earlier bone integration and a treatment for peri implantitis bone loss around existing implants Our
bifunctional peptide coating uses a water soluble small peptide to anchor and present a second bioactive
molecule on the implant surface In this proof of concept we chose a small molecule that transiently activates
the Wnt pathway in stem cells for bone formation to drive early integration and treat peri implantitis bone loss
to extend the life of existing implants
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing